Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Phillips

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|November 14, 2013
Brief exposure to a self-paced computer-based reading programme and how it impacts reading ability and behaviour problemsJ Antony Hughes, Gordon Phillips, Phil Reed
Leukemia Research|April 4, 2007
Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cellsJane L Liesveld, Jeremy Bechelli, Karen Rosell, et al.
Hematology (Amsterdam, Netherlands)|December 3, 2005
Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibitionJane L Liesveld, Karen E Rosell, Chaohui Lu, et al.
Leukemia & Lymphoma|October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab eraMakiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2009
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab eraTithi Biswas, Sughosh Dhakal, Rui Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2004
Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patientsJohn S Thompson, Claire Pomeroy, Richard J Kryscio, et al.
Leukemia Research|June 24, 2008
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AMLAlison R Walker, Rami S Komrokji, Jainulabdeen Ifthikharuddin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|November 14, 2013
Brief exposure to a self-paced computer-based reading programme and how it impacts reading ability and behaviour problemsJ Antony Hughes, Gordon Phillips, Phil Reed
Leukemia Research|April 4, 2007
Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cellsJane L Liesveld, Jeremy Bechelli, Karen Rosell, et al.
Hematology (Amsterdam, Netherlands)|December 3, 2005
Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibitionJane L Liesveld, Karen E Rosell, Chaohui Lu, et al.
Leukemia & Lymphoma|October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab eraMakiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2009
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab eraTithi Biswas, Sughosh Dhakal, Rui Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2004
Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patientsJohn S Thompson, Claire Pomeroy, Richard J Kryscio, et al.
Leukemia Research|June 24, 2008
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AMLAlison R Walker, Rami S Komrokji, Jainulabdeen Ifthikharuddin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Pageof 1